Literature DB >> 18373193

Introduction: anemia in heart failure.

Inder Anand1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18373193     DOI： 10.1007/s10741-008-9093-y

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN： 1382-4147            Impact factor:   4.214


× No keyword cloud information.
  5 in total

1.  Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis.

Authors:  Arintaya Phrommintikul; Steven Joseph Haas; Maros Elsik; Henry Krum
Journal:  Lancet       Date:  2007-02-03       Impact factor: 79.321

Review 2.  Pathogenesis of anemia in cardiorenal disease.

Authors:  Inder S Anand
Journal:  Rev Cardiovasc Med       Date:  2005       Impact factor: 2.930

3.  The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.

Authors:  D S Silverberg; D Wexler; M Blum; G Keren; D Sheps; E Leibovitch; D Brosh; S Laniado; D Schwartz; T Yachnin; I Shapira; D Gavish; R Baruch; B Koifman; C Kaplan; S Steinbruch; A Iaina
Journal:  J Am Coll Cardiol       Date:  2000-06       Impact factor: 24.094

4.  Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones.

Authors:  I S Anand; Y Chandrashekhar; R Ferrari; P A Poole-Wilson; P C Harris
Journal:  Br Heart J       Date:  1993-10

Review 5.  Anemia and chronic heart failure implications and treatment options.

Authors:  Inder S Anand
Journal:  J Am Coll Cardiol       Date:  2008-08-12       Impact factor: 24.094
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.